International
Collaborative research by Deep Bio and Dr. Lotan research team at Johns Hopkins Medicine was revealed at AUA 2023 SEOUL, SOUTH KOREA (PRWEB) MAY 11, 2023 - Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics support...
Evident Corporation (“Evident”) today announced the appointment of Eric Anderson, a current member of the Office of the CEO, as Interim CEO. He takes on the responsibilities of Yoshitake Saito, who assumes the role of Chairman effective...
Lunit and collaborators demonstrate the predictive value and analytical prowess of Lunit's AI-biomarker platform in a wide range of cancer types and clinical practices SEOUL, South Korea, May 10, 2023 /PRNewswire/ -- Lunit...
NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a EUR 1.300.000 EFRO-OOST grant alongside Radboud university medical center and Pathologie-DNA to...
The Institute of Human Biology aims to better predict which drug candidates are safe and most effective in patients by evolving and increasing the use of human model systems. Human model systems are miniature living 'replicas' of...
NIJMEGEN, The Netherlands--(BUSINESS WIRE)--Aiosyn, a software company that develops AI-powered pathology software, has announced the integration of its AI-powered automated quality control (QC) algorithm in the Sectra Amplifier Marketplace....
